Ranbaxy Laboratories’ Synriam wins Innovation Excellence Platinum Award

16 Jul 2013 Evaluate

Ranbaxy Laboratories, the country’s largest pharmaceutical company, has been conferred with the Innovation Excellence Platinum Award at the ASSOCHAM Innovation Awards 2013 in the Science & Technology category for its new anti-malaria drug, Synriam. The prestigious award was given by Minister for Science & Technology and Earth Sciences, Jaipal Reddy.

Synriam, was launched by the company last year on April 25 (World Malaria Day). The drug is used for the treatment of plasmodium falciparum malaria, in adults. The company is working to make this new treatment available in African, Asian and South American markets where Malaria is rampant.

As per IMS data, over 2 million Synriam pills have been sold since its launch and over 700,000 patients have been treated in India.

Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×